Vaccine Effectiveness, Burden and Impact Studies (VEBIS) of COVID-19 and Influenza – Tender Specifications OJ/2021/DPR/12924  Regular laboratory results summary table to ECDC specifying the number of  laboratory specimens processed and tested and the proportion of positive samples  by study site, stratified by key variables. The contractor should ensure that all study subjects are tested according to the  protocols with a validated laboratory assay and will report regularly overview  results. On a regular frequency, updates on the number of molecular tests/serology  will provide the summary of the implementation of laboratory-related aspects of the  vaccine effectiveness studies.  Task 4: Summarize findings related to the study  The contractor will summarize findings related to the studies, which include delivering comprehensive reports on the results of the vaccine effectiveness  studies, draft manuscripts on topics related to the vaccine-related studies in long-term care facilities,  ad hoc  presentations or brief summaries upon request  of ECDC on vaccine-related topics on the studies in long-term care facilities. Deliverable (DL)  Description  Estimated  frequency/ Volume  File / form at type  DL 3.4.1. Annual  epidemiological  descriptive and  analytical report Descriptive and analytical report.  Deliverable includes scripts used to create the analysis report. Cumulative data  presented since the beginning of data collection. Format of the reports to be agreed  with ECDC during monthly conference calls.  The report should include descriptive data on study participants and recruitment.  The descriptive data should also be stratified by vaccine brand name, site, age  group, sex and other relevant variables. Vaccine effectiveness estimates against primary and secondary study outcomes  should also be included by compiling data from each country and should be  stratified by vaccine brand name, site, age group, sex and other relevant variables.  On an annual basis  Word - ECDC  template 